RECRUITING Not applicable ClinicalTrials.gov

Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music

Sponsor: NORCE Norwegian Research Centre AS • ClinicalTrials.gov ID: NCT07028983

Registry updated: 2026-09-10

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

FALCO is a parallel pragmatic randomized control trial addressing long-term effects of music therapy (MT) on substance use disorder (SUD). 600 participants will be recruited from multiple European countries (see Locations). They will be randomized into one of the following intervention arms: Active Music Group (AMG), Music Listening Group (MLG) or Treatment as Usual (TAU) as offered locally.

Interventions

Active Music Group (AMG) (Behavioral)
Active music group is a music therapy intervention where participants actively make/play music in groups. The sessions will be conducted by an appropriately qualified music therapist.
Music Listening Group (MLG) (Behavioral)
Music listening group is a music therapy intervention where participants partake in music listening in groups. The sessions will be conducted by an appropriately qualified music therapist.
Treatment as Usual (TAU) (Behavioral)
Treatment as usual as provided locally, which may include pharmacological and/or non-pharmacological interventions (e.g. mindfulness-based intervention, structured physical activity).

Eligibility criteria

Inclusion Criteria: * patients seeking or receiving treatment at the recruitment site for an existing substance use disorder based on ICD-10 criteria * ≥18 years old * not currently undergoing detoxification (detoxification has been completed or is not currently planned at the time of recruitment) * any type of substance use including polysubstance and alcohol use Exclusion Criteria: * exclusively nicotine dependence * psychotic episode in the last 3 months * insufficient language skills to participate in treatment without the use of a translator * hearing impairment that considerably impairs hearing of music played at a moderate volume (not relevant if hearing is sufficiently compensated by a hearing aid) * existing diagnosis of dementia * is currently receiving music therapy or has received music therapy (i.e. at planned and reoccurring intervals, not counting single random occurrences) during the past year

Conditions

Substance Use Disorder (SUD)

Locations

Anton Proksch Institut — Vienna, Austria
Herzog College — Jerusalem, Israel
University of Pavia — Pavia, Italy
University of Bergen / NORCE Research AS — Bergen, Norway
Sykehuset Innlandet — Innlandet, Norway
Stavanger Universitetssjukehus — Stavanger, Norway
Palestinian National Rehabilitation Centre — Bethlehem, Palestinian Territories
WOTU / University of Gdansk — Gdansk, Poland
Fundacio Sanitaria d'Igualada — Barcelona, Spain
IDIBGI — Girona, Spain
CAD — Zurich, Switzerland

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment